Simplex Trading’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-3,049
Closed -$57K 8386
2019
Q1
$57K Buy
+3,049
New +$49.5K ﹤0.01% 4912
2017
Q2
Sell
-27,970
Closed -$134K 7460
2017
Q1
$134K Buy
+27,970
New +$152K 0.01% 1508
2016
Q4
Sell
-219
Closed -$1.12K 7225
2016
Q3
$1K Buy
+219
New +$1.12K ﹤0.01% 5673
2016
Q2
Sell
-6,725
Closed -$36.2K 7085
2016
Q1
$38K Sell
6,725
-1,913
-22% -$13.4K ﹤0.01% 2218
2015
Q4
$89K Buy
8,638
+6,907
+399% +$93.7K 0.01% 1455
2015
Q3
$31K Buy
1,731
+1,546
+836% +$29.8K ﹤0.01% 2381
2015
Q2
$3K Buy
185
+37
+25% +$655 ﹤0.01% 4213
2015
Q1
$2K Sell
148
-3,484
-96% -$58.5K ﹤0.01% 4339
2014
Q4
$58K Buy
+3,632
New +$48.6K 0.01% 1282

Other funds holding OSIR

Simplex Trading's OSIR Position: Q2 2019 in Review

Simplex Trading sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2019, closing a stake of 3,049 shares — an estimated $57K sold.

Simplex Trading first reported a position in OSIR in Q4 2014 and held it in 9 quarters. The position peaked at $134K in Q1 2017. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.

  • Simplex Trading reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Simplex Trading sold 3,049 Osiris Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $57K.
  • Simplex Trading first reported a position in Osiris Therapeutics, Inc. Common Stock in Q4 2014 and held it in 9 quarters.
  • Simplex Trading's Osiris Therapeutics, Inc. Common Stock position peaked at $134K in Q1 2017.
  • 1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Simplex Trading's 13F filing for Q2 2019, filed 26 Jul 2019.